CIK 0002058707 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Attovia Therapeutics, Inc.
Sign in to watch- Ticker
- ATTO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 921510574
- Phone
- 5103995001
- Business address
- 1091 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-04 | Attovia Therapeutics, Inc. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2026-08-04 | Attovia Therapeutics, Inc. President and CEO | Grant or award · Stock Option (Right to Buy) | +538,300 | 538,300 |
Page 9 of 9 · 162 trades